Clinical trial
Clinical Application of an AI-based Dissection Trajectory Prediction System (ADTPS) in Endoscopic Submucosal Dissection: A Prospective Paired Diagnostic Study and a Randomized Controlled Clinical Trial
NCT07757906 is registered in ClinicalTrials.gov with Qilu Hospital of Shandong University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Application of an AI-based Dissection Trajectory Prediction System (ADTPS) in Endoscopic Submucosal Dissection: A Prospective Paired Diagnostic Study and a Randomized Controlled Clinical Trial
- Lead sponsor
- Qilu Hospital of Shandong University
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- July 29, 2026
- Completion date
- October 1, 2027
- Enrollment
- 220 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ai-based dissection trajectory prediction system, esophageal squamous cell carcinoma (escc), high-grade intraepithelial neoplasia